• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析前慢性肾脏病患者骨质疏松的危险因素及临床预测模型。

Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients.

机构信息

Nephrology Department, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.

Nuclear Medicine, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.

出版信息

Ren Fail. 2024 Dec;46(2):2361802. doi: 10.1080/0886022X.2024.2361802. Epub 2024 Jun 14.

DOI:10.1080/0886022X.2024.2361802
PMID:38874080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11182074/
Abstract

BACKGROUND

Osteoporosis in pre-dialysis chronic kidney disease (CKD) patients has been overlooked, and the risk factors of osteoporosis in these patients have not been adequately studied.

OBJECTIVE

To identify risk factors for osteoporosis in pre-dialysis CKD patients and develop predictive models to estimate the likelihood of osteoporosis.

METHODS

Dual-energy X-ray absorptiometry was used to measure bone mineral density, and clinical examination results were collected from 326 pre-dialysis CKD patients. Binary logistic regression was employed to explore the risk factors associated with osteoporosis and develop predictive models.

RESULTS

In this cohort, 53.4% ( = 174) were male, 46.6% ( = 152) were female, and 21.8% ( = 71) were diagnosed with osteoporosis. Among those diagnosed with osteoporosis, 67.6% ( = 48) were female and 32.4% ( = 23) were male. Older age and low 25-(OH)-Vitamin D levels were identified as risk factors for osteoporosis in males. For females, older age, being underweight, higher bone alkaline phosphatase (NBAP), and advanced CKD (G5) were significant risk factors, while higher iPTH was protective. Older age, being underweight, and higher NBAP were risk factors for osteoporosis in the G1-4 subgroup. In the G5 subgroup, older age and higher NBAP increased the risk, while high 25-(OH)-Vitamin D or iPTH had protective effects. Nomogram models were developed to assess osteoporosis risk in pre-dialysis patients based on gender and renal function stage.

CONCLUSION

Risk factors for osteoporosis vary by gender and renal function stages. The nomogram clinical prediction models we constructed may aid in the rapid screening of patients at high risk of osteoporosis.

摘要

背景

透析前慢性肾脏病(CKD)患者的骨质疏松症一直被忽视,这些患者的骨质疏松症危险因素尚未得到充分研究。

目的

确定透析前 CKD 患者骨质疏松症的危险因素,并建立预测模型来估计骨质疏松症的可能性。

方法

使用双能 X 射线吸收法测量骨矿物质密度,并从 326 名透析前 CKD 患者中收集临床检查结果。采用二元逻辑回归分析探讨与骨质疏松症相关的危险因素,并建立预测模型。

结果

在该队列中,53.4%( = 174)为男性,46.6%( = 152)为女性,21.8%( = 71)被诊断为骨质疏松症。在诊断为骨质疏松症的患者中,67.6%( = 48)为女性,32.4%( = 23)为男性。年龄较大和 25-(OH)-维生素 D 水平较低被确定为男性骨质疏松症的危险因素。对于女性,年龄较大、体重不足、骨碱性磷酸酶(NBAP)较高和 CKD 进展(G5)是显著的危险因素,而较高的 iPTH 则具有保护作用。年龄较大、体重不足和 NBAP 较高是 G1-4 亚组骨质疏松症的危险因素。在 G5 亚组中,年龄较大和 NBAP 较高增加了风险,而较高的 25-(OH)-维生素 D 或 iPTH 具有保护作用。我们基于性别和肾功能分期开发了诺莫图模型来评估透析前患者的骨质疏松症风险。

结论

骨质疏松症的危险因素因性别和肾功能分期而异。我们构建的诺莫图临床预测模型可能有助于快速筛选骨质疏松症高危患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/f347f58755eb/IRNF_A_2361802_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/5cf01c6034a2/IRNF_A_2361802_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/f347f58755eb/IRNF_A_2361802_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/5cf01c6034a2/IRNF_A_2361802_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/f347f58755eb/IRNF_A_2361802_F0002_C.jpg

相似文献

1
Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients.透析前慢性肾脏病患者骨质疏松的危险因素及临床预测模型。
Ren Fail. 2024 Dec;46(2):2361802. doi: 10.1080/0886022X.2024.2361802. Epub 2024 Jun 14.
2
Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.新诊断的晚期透析前糖尿病肾病患者慢性肾脏病相关矿物质骨异常的概况:一项基于医院的横断面研究。
Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S931-S937. doi: 10.1016/j.dsx.2017.07.019. Epub 2017 Jul 8.
3
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].慢性肾脏病患者骨质疏松症的诊断与治疗:奥地利骨与矿物质研究学会(ÖGKM)、奥地利物理与康复医学学会(ÖGPMR)及奥地利肾脏病学会(ÖGN)联合指南
Wien Med Wochenschr. 2023 Oct;173(13-14):299-318. doi: 10.1007/s10354-022-00989-0. Epub 2022 Dec 21.
4
Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.慢性肾脏病透析患者骨量丢失的骨密度及血清生化预测指标
Clin J Am Soc Nephrol. 2014 Jul;9(7):1254-62. doi: 10.2215/CJN.09470913. Epub 2014 Jun 19.
5
Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.慢性肾脏病 5 期患者 2 年皮质骨和小梁骨丢失:生化和临床预测因素。
Osteoporos Int. 2018 Jan;29(1):125-134. doi: 10.1007/s00198-017-4228-4. Epub 2017 Oct 9.
6
Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.非透析慢性肾脏病患者低骨密度的危险因素和肾脏结局。
Osteoporos Int. 2020 Dec;31(12):2373-2382. doi: 10.1007/s00198-020-05531-9. Epub 2020 Jul 8.
7
High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis.透析前慢性肾脏病患者低骨矿物质密度的高患病率:骨组织形态计量学分析
Clin Nephrol. 2004 Dec;62(6):432-9. doi: 10.5414/cnp62432.
8
Bone mineral density in patients with predialysis chronic kidney disease.透析前慢性肾脏病患者的骨矿物质密度。
Ren Fail. 2013 Sep;35(8):1105-11. doi: 10.3109/0886022X.2013.815102. Epub 2013 Jul 23.
9
Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.晚期肾脏病患者骨质疏松症的诊断与治疗:综述
Am J Kidney Dis. 2022 Mar;79(3):427-436. doi: 10.1053/j.ajkd.2021.06.031. Epub 2021 Aug 20.
10
Chronic kidney disease is associated with low BMD at the hip but not at the spine.慢性肾脏病与髋部而不是脊柱的低骨密度有关。
Osteoporos Int. 2019 May;30(5):1015-1023. doi: 10.1007/s00198-019-04864-4. Epub 2019 Jan 28.

引用本文的文献

1
Subgroup-Specific Osteoporosis Risk in Chronic Kidney Disease: Insights from a Nationwide Korean Cohort.慢性肾脏病中特定亚组的骨质疏松风险:来自韩国全国队列的见解
Biomedicines. 2025 Aug 11;13(8):1956. doi: 10.3390/biomedicines13081956.
2
Machine learning models to predict osteoporosis in patients with chronic kidney disease stage 3-5 and end-stage kidney disease.用于预测慢性肾脏病3-5期及终末期肾病患者骨质疏松症的机器学习模型。
Sci Rep. 2025 Apr 3;15(1):11391. doi: 10.1038/s41598-025-95928-5.
3
The Management of Osteoporosis in Chronic Kidney Disease: A Review of Diagnostic and Therapeutic Approaches.

本文引用的文献

1
Establishing age-adjusted trabecular bone score curves using dual-energy X-ray absorptiometry in Chinese women and men: a cross-sectional study.在中国女性和男性中使用双能X线吸收法建立年龄校正的小梁骨评分曲线:一项横断面研究。
Quant Imaging Med Surg. 2023 Apr 1;13(4):2478-2485. doi: 10.21037/qims-22-550. Epub 2023 Mar 10.
2
Management of osteoporosis in patients with chronic kidney disease.慢性肾脏病患者骨质疏松症的管理。
Osteoporos Int. 2022 Nov;33(11):2259-2274. doi: 10.1007/s00198-022-06462-3. Epub 2022 Jun 24.
3
Early Menopause May Associate With a Higher Risk of CKD and All-Cause Mortality in Postmenopausal Women: An Analysis of NHANES, 1999-2014.
慢性肾脏病中骨质疏松症的管理:诊断与治疗方法综述
Cureus. 2024 Nov 17;16(11):e73882. doi: 10.7759/cureus.73882. eCollection 2024 Nov.
4
Individualizing the lifesaving journey for calciphylaxis: addressing rapidly progressive attacks with multidimensional and AI research for regenerative medicine.为钙过敏症量身定制挽救生命之旅:通过再生医学的多维度和人工智能研究应对快速进展性发作。
Ren Fail. 2024 Dec;46(2):2392846. doi: 10.1080/0886022X.2024.2392846. Epub 2024 Sep 5.
早期绝经可能与绝经后女性患慢性肾脏病及全因死亡风险较高相关:对1999 - 2014年美国国家健康与营养检查调查(NHANES)的分析
Front Med (Lausanne). 2022 Mar 18;9:823835. doi: 10.3389/fmed.2022.823835. eCollection 2022.
4
High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women.高循环卵泡刺激素水平是绝经后妇女肾功能障碍的潜在危险因素。
Front Endocrinol (Lausanne). 2021 Apr 1;12:627903. doi: 10.3389/fendo.2021.627903. eCollection 2021.
5
American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update.美国临床内分泌医师协会/美国内分泌学会绝经后骨质疏松症诊断与治疗临床实践指南 - 2020年更新版
Endocr Pract. 2021 Apr;27(4):379-380. doi: 10.1016/j.eprac.2021.02.001. Epub 2021 Feb 9.
6
Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis.慢性肾脏病 3a-G5D 患者髋关节和非椎体骨折的风险:系统评价和荟萃分析。
Am J Kidney Dis. 2020 Oct;76(4):521-532. doi: 10.1053/j.ajkd.2020.02.450. Epub 2020 Jul 9.
7
Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.非透析慢性肾脏病患者低骨密度的危险因素和肾脏结局。
Osteoporos Int. 2020 Dec;31(12):2373-2382. doi: 10.1007/s00198-020-05531-9. Epub 2020 Jul 8.
8
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.美国临床内分泌医师协会/美国内分泌学会 2020 年绝经后骨质疏松症诊断和治疗临床实践指南更新版
Endocr Pract. 2020 May;26(Suppl 1):1-46. doi: 10.4158/GL-2020-0524SUPPL.
9
The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone.终末期肾病患者的椎体骨折发生率和流行率,以及甲状旁腺激素的作用。
Osteoporos Int. 2020 Mar;31(3):515-524. doi: 10.1007/s00198-019-05187-0. Epub 2019 Nov 14.
10
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 2017慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南更新
Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.